INS and Insulin resistance: Mirroring these findings, a mouse model of NS-ML, expressing a hypoactivating mutation of SHP2 (SHP2 T468M/+), displayed insulin hypersensitivity and protection to HFD-induced insulin resistance, although it shares with NS the reduced adiposity.